The Scientific Research team at Mirimus focuses on advancing the field of drug discovery by developing and utilizing sophisticated RNA interference (RNAi) animal models. They specialize in predicting the toxicities of potential drug therapies, thereby eliminating the need for actual drug testing during the preclinical phase. Their diverse expertise spans biotechnology, cell biology, neuroscience, immunology, cancer biology, genetics, and genetic engineering to ensure comprehensive and innovative research outcomes.